MEDP Investors Have Opportunity to Lead Medpace Holdings Securities Fraud Lawsuit

The Schall Law Firm reminds investors of a class action lawsuit against Medpace Holdings, Inc. for securities fraud violations.

Apr. 10, 2026 at 7:56pm

Got story updates? Submit your updates here. ›

A photorealistic studio still life featuring a stack of legal documents, a gavel, and a pair of glasses, symbolizing the abstract concepts of corporate fraud, securities litigation, and investor protection.A legal case against alleged corporate fraud aims to recover losses and uphold shareholder rights.Los Angeles Today

The Schall Law Firm, a national shareholder rights litigation firm, has reminded investors of a class action lawsuit against Medpace Holdings, Inc. (NASDAQ: MEDP) for violations of securities laws. Investors who purchased the company's securities between April 22, 2025 and February 9, 2026 are encouraged to contact the firm before June 5, 2026 to participate in the lawsuit.

Why it matters

This lawsuit alleges that Medpace engaged in a scheme to artificially inflate its share price, leading to investor losses when the truth about the company's performance became evident. Securities fraud lawsuits aim to hold companies accountable for misrepresenting their financial health and protect investors from such deceptive practices.

The details

According to the complaint, Medpace made false and misleading statements to the market, which became evident through the company's poor performance throughout the class period. The Schall Law Firm, which specializes in securities class action lawsuits, is representing investors in this case.

  • The class period is from April 22, 2025 to February 9, 2026.
  • The deadline to contact the Schall Law Firm to participate in the lawsuit is June 5, 2026.

The players

Medpace Holdings, Inc.

A clinical research organization that provides clinical development services to the pharmaceutical, biotechnology, and medical device industries.

The Schall Law Firm

A national shareholder rights litigation firm that specializes in securities class action lawsuits and shareholder rights litigation.

Got photos? Submit your photos here. ›

What they’re saying

“We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.”

— Brian Schall, Attorney, Schall Law Firm

What’s next

The judge will decide on June 5, 2026 whether to certify the class in this securities fraud lawsuit against Medpace Holdings.

The takeaway

This case highlights the importance of holding public companies accountable for misrepresenting their financial health and the role of shareholder litigation in protecting investor rights. Investors who suffered losses due to Medpace's alleged fraud have until June 5, 2026 to join the class action lawsuit.